We’re a leading bioscience company focused on accelerating new and innovative medical solutions for positive impact.
Stay up to date. Find out about our latest research, products, exclusive partnerships and more.
XPhyto brings together cutting-edge companies and top researchers from around the world to innovate, accelerate and commercialize disruptive technology, from drug delivery formulations to diagnostics.
Innovative and Cutting-Edge Solutions
Precision transdermal and oral drug formulations
Point-of-care (POC) diagnostics including rapid infectious disease screening
Production, formulation and validation of new active pharmaceutical ingredients (APIs)
Our research and innovation have the potential to impact lives around the world.
Learn more about how XPhyto products could change the lives of people suffering from conditions and how our new research may impact the state of our global community.
Sep 8, 2021
Vancouver, Canada, and Frankfurt, Germany (September 08, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...
Aug 30, 2021
Biosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutesEasy and simple at-home self-checks improve oral health...
Jul 28, 2021
First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto’s oral dissolvable delivery platformBiosensor candidates are ready for optimization and performance assessmentDevelopment of...
Learn more about XPhyto’s innovation to impact strategy and get access to XPhyto investor information.
CSE:XPHY FSE:4XT OTCQB:XPHYF
